Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference newsletter

Ovarian Neoplasms

Free Subscription 21.09.2020 1 Cancer 3 Clin Cancer Res 3 Gynecol Oncol 1 J Natl Cancer Inst 1 Oncology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cancer

1. GHIRARDI V, Ronsini C, Trozzi R, Di Ilio C, et al
   Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
   Cancer. 2020 Sep 15. doi: 10.1002/cncr.33167.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

2. YANG H, Mao W, Rodriguez-Aguayo C, Mangala LS, et al
   Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
   Clin Cancer Res. 2020;26:5050.
   PubMed        
   
   
3. JIN ZH, Tsuji AB, Degardin M, Sugyo A, et al
   Radiotheranostic Agent (64)Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer.
   Clin Cancer Res. 2020 Sep 15. pii: 1078-0432.CCR-20-1205.
   PubMed         Abstract available
   
   
4. JORDAN K, Sikora MJ, Slansky JE, Minic A, et al
   The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval.
   Clin Cancer Res. 2020 Sep 14. pii: 1078-0432.CCR-20-1762.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

5. HURWITZ LM, Pinsky PF, Huang WY, Freedman ND, et al
   Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial.
   Gynecol Oncol. 2020 Sep 10. pii: S0090-8258(20)33855.
   PubMed         Abstract available
   
   
6. PLETT H, Filippova OT, Garbi A, Kommoss S, et al
   Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
   Gynecol Oncol. 2020 Sep 9. pii: S0090-8258(20)33829.
   PubMed         Abstract available
   
   
7. MADARIAGA A, Garg S, Bruce JP, Thiryayi S, et al
   Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer.
   Gynecol Oncol. 2020 Sep 7. pii: S0090-8258(20)33849.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

8. VOS JR, Ligtenberg MJL, Hoogerbrugge N
   Response to Tomao, Panici, and Tomao.
   J Natl Cancer Inst. 2020;112:425.
   PubMed        
   
   

   
   Oncology

9. STEFFEN T, Haller L, Bijelic L, Glatzer M, et al
   Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI).
   Oncology. 2020 Sep 11:1-8. doi: 10.1159/000510098.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: